There are millions of Americans who struggle to manage complex, chronic and rare diseases. They, as well as their families and caregivers, rely on medical technology to not only save and extend lives, but also improve quality of life. On their behalf, the undersigned patient advocacy, disability, research, community, and healthcare industry organizations are writing to express our deep concern about the impact of the medical device excise tax, which will soon be reinstated, and the future of vital medical technology innovation.
Posted in Letters and Comments